ImmuCell Debt to Equity Ratio 2010-2025 | ICCC
Current and historical debt to equity ratio values for ImmuCell (ICCC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ImmuCell debt/equity for the three months ending March 31, 2025 was 0.30.
| ImmuCell Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.02B | $0.03B | 0.57 |
| 2024-12-31 | $0.02B | $0.03B | 0.64 |
| 2024-09-30 | $0.02B | $0.03B | 0.68 |
| 2024-06-30 | $0.02B | $0.02B | 0.78 |
| 2024-03-31 | $0.02B | $0.03B | 0.75 |
| 2023-12-31 | $0.02B | $0.03B | 0.75 |
| 2023-09-30 | $0.02B | $0.03B | 0.71 |
| 2023-06-30 | $0.02B | $0.03B | 0.64 |
| 2023-03-31 | $0.02B | $0.03B | 0.53 |
| 2022-12-31 | $0.01B | $0.03B | 0.48 |
| 2022-09-30 | $0.01B | $0.03B | 0.45 |
| 2022-06-30 | $0.01B | $0.03B | 0.41 |
| 2022-03-31 | $0.01B | $0.03B | 0.41 |
| 2021-12-31 | $0.01B | $0.03B | 0.37 |
| 2021-09-30 | $0.01B | $0.03B | 0.36 |
| 2021-06-30 | $0.01B | $0.03B | 0.36 |
| 2021-03-31 | $0.01B | $0.03B | 0.42 |
| 2020-12-31 | $0.01B | $0.03B | 0.43 |
| 2020-09-30 | $0.01B | $0.03B | 0.43 |
| 2020-06-30 | $0.01B | $0.03B | 0.44 |
| 2020-03-31 | $0.01B | $0.03B | 0.38 |
| 2019-12-31 | $0.01B | $0.03B | 0.34 |
| 2019-09-30 | $0.01B | $0.03B | 0.33 |
| 2019-06-30 | $0.01B | $0.03B | 0.33 |
| 2019-03-31 | $0.01B | $0.03B | 0.34 |
| 2018-12-31 | $0.01B | $0.02B | 0.51 |
| 2018-09-30 | $0.01B | $0.02B | 0.47 |
| 2018-06-30 | $0.01B | $0.02B | 0.44 |
| 2018-03-31 | $0.01B | $0.02B | 0.43 |
| 2017-12-31 | $0.01B | $0.02B | 0.45 |
| 2017-09-30 | $0.01B | $0.02B | 0.45 |
| 2017-06-30 | $0.01B | $0.02B | 0.39 |
| 2017-03-31 | $0.01B | $0.02B | 0.24 |
| 2016-12-31 | $0.01B | $0.02B | 0.25 |
| 2016-09-30 | $0.00B | $0.02B | 0.25 |
| 2016-06-30 | $0.00B | $0.02B | 0.26 |
| 2016-03-31 | $0.00B | $0.02B | 0.25 |
| 2015-12-31 | $0.00B | $0.01B | 0.37 |
| 2015-09-30 | $0.00B | $0.01B | 0.38 |
| 2015-06-30 | $0.00B | $0.01B | 0.14 |
| 2015-03-31 | $0.00B | $0.01B | 0.15 |
| 2014-12-31 | $0.00B | $0.01B | 0.19 |
| 2014-09-30 | $0.00B | $0.01B | 0.18 |
| 2014-06-30 | $0.00B | $0.01B | 0.18 |
| 2014-03-31 | $0.00B | $0.01B | 0.18 |
| 2013-12-31 | $0.00B | $0.01B | 0.17 |
| 2013-09-30 | $0.00B | $0.01B | 0.16 |
| 2013-06-30 | $0.00B | $0.01B | 0.20 |
| 2013-03-31 | $0.00B | $0.01B | 0.18 |
| 2012-12-31 | $0.00B | $0.01B | 0.20 |
| 2012-09-30 | $0.00B | $0.01B | 0.19 |
| 2012-06-30 | $0.00B | $0.01B | 0.19 |
| 2012-03-31 | $0.00B | $0.01B | 0.21 |
| 2011-12-31 | $0.00B | $0.01B | 0.22 |
| 2011-09-30 | $0.00B | $0.01B | 0.22 |
| 2011-06-30 | $0.00B | $0.01B | 0.25 |
| 2011-03-31 | $0.00B | $0.01B | 0.23 |
| 2010-12-31 | $0.00B | $0.01B | 0.16 |
| 2010-09-30 | $0.00B | $0.01B | 0.15 |
| 2010-06-30 | $0.00B | $0.01B | 0.03 |
| 2010-03-31 | $0.00B | $0.01B | 0.04 |
| 2009-12-31 | $0.00B | $0.01B | 0.04 |
| 2009-09-30 | $0.00B | $0.01B | 0.03 |
| 2009-06-30 | $0.00B | $0.01B | 0.04 |
| 2009-03-31 | $0.00B | $0.01B | 0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.059B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $151.037B | 37.81 |
| Stryker (SYK) | United States | $146.527B | 30.64 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $112.146B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.313B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.826B | 28.39 |
| ResMed (RMD) | United States | $36.979B | 27.77 |
| Agilent Technologies (A) | United States | $32.895B | 21.44 |
| GE HealthCare Technologies (GEHC) | United States | $32.794B | 15.57 |
| Terumo (TRUMY) | Japan | $26.561B | 34.50 |
| Koninklijke Philips (PHG) | Netherlands | $22.051B | 15.85 |
| Insulet (PODD) | United States | $21.941B | 86.12 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.277B | 11.74 |
| Baxter (BAX) | United States | $15.529B | 11.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.253B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.430B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.971B | 20.78 |
| Lantheus Holdings (LNTH) | United States | $5.642B | 14.23 |
| Prestige Consumer Healthcare (PBH) | United States | $4.203B | 18.78 |
| Perrigo (PRGO) | Ireland | $3.596B | 9.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.385B | 15.42 |
| ICU Medical (ICUI) | United States | $3.275B | 24.15 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $1.997B | 13.73 |
| LeMaitre Vascular (LMAT) | United States | $1.901B | 42.49 |
| AtriCure (ATRC) | United States | $1.730B | 0.00 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.201B | 12.19 |
| Neogen (NEOG) | United States | $1.131B | 14.47 |
| BioLife Solutions (BLFS) | United States | $1.126B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.100B | 24.74 |
| Kestra Medical Technologies (KMTS) | United States | $1.063B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.895B | 9.02 |
| Capricor Therapeutics (CAPR) | United States | $0.650B | 0.00 |
| Evolus (EOLS) | United States | $0.647B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Owens & Minor (OMI) | United States | $0.619B | 5.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.584B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Surmodics (SRDX) | United States | $0.420B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.408B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.76 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 57.20 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.87 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Biote (BTMD) | United States | $0.210B | 5.89 |
| Quanterix (QTRX) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.25 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.86 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Jin Medical (ZJYL) | China | $0.120B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.59 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.14 |
| Nephros (NEPH) | United States | $0.036B | 48.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |